Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 41
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of which...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    You have mail: Stem Cell messages for fighting liver diseases

    The use of stem cells is currently limited by issues including the risk of tumor formation or undesired immune...

    Backer Badge Funded